Clinical Trials Logo
  1. Home
  2. Mitral Regurgitation
  3. NCT04820764
  4. Details
NCT04820764 Clinical Trial

EFS of the CardioMech MVRS

Mitral Regurgitation Clinical Trial

Official title:
Early Feasibility Study of the CardioMech Mitral Valve Repair System (MVRS)

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04820764
Other study ID # 10228
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 27, 2021
Est. completion date June 2029

Study information
Verified date May 2024
Source CardioMech AS
Contact Danielle Dusenberry
Phone 631-365-9399
Email Danielle.Dusenberry@cardiomech.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.

Description:

The purpose of the clinical study is to obtain clinical data on the CardioMech Mitral Valve Repair System (MVRS) in patients diagnosed with moderate to severe (≥3+) or severe (≥4+), symptomatic, degenerative mitral regurgitation and who are determined to be at intermediate or high surgical risk for mitral valve repair, as assessed by the site's multidisciplinary heart team.

Recruitment information / eligibility
Status Recruiting
Enrollment 10
Est. completion date June 2029
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Eighteen (18) years of age or greater - Moderate to severe (=3+) or severe (=4+) mitral valve regurgitation (per American Society of Echocardiography (ASE) guidelines) due to mitral valve prolapse or flail - Intermediate or high surgical risk for mitral valve repair Exclusion Criteria: - History of rheumatic heart disease - History of prior endocarditis - History of prior repair or replacement of the mitral valve, annuloplasty or valvuloplasty or has a left atrial appendage closure device - Severely calcified mitral leaflet or has evidence of calcification in the grasping area of the leaflets that would prevent leaflet anchor positioning and deployment - Complex mechanism of MR (leaflet perforation, severe leaflet calcifications, commissural extension, commissural prolapse, multiple flail or prolapsing segments, cleft) present on required imaging

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• CardioMech MVRS
CardioMech MVRS

Locations
Country Name City State
United States Atrium Health Sanger Heart and Vascular Institute Charlotte North Carolina
United States Intermountain Medical Center Murray Utah
United States Ascension St. Thomas West Nashville Tennessee
United States NYU Langone New York New York
United States Mayo Clinic Rochester Minnesota
United States CentraCare Heart & Vascular Center Saint Cloud Minnesota
United States Cardiovascular Institute of Los Robles Health System Thousand Oaks California
United States Ascension St. Francis via Christi Wichita Kansas

Sponsors (1)
Lead Sponsor Collaborator
CardioMech AS

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Freedom from serious adverse events determined to be related to the CardioMech MVRS device or procedure 30 days
Primary Change in MR grade 30 days
See also
  Status Clinical Trial Phase
Completed NCT03278574 - Flexible Band vs Rigid Ring for Degenerative Mitral Valve Disease N/A
Suspended NCT04960280 - A Study to Evaluate a Computerized Stethoscope Called ©Voqx to Diagnose Heart Disease N/A
Recruiting NCT05021614 - Valveclip® Transcatheter Mitral Valve Repair Study N/A
Not yet recruiting NCT06465745 - AltaValve Pivotal Trial N/A
Not yet recruiting NCT06167213 - ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral N/A
Withdrawn NCT05040451 - Carillon Mitral Contour System for Treatment of Exercise Induced Functional Mitral Regurgitation
Withdrawn NCT03714412 - Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System N/A
Recruiting NCT02592889 - (MitraClip in Non-Responders to Cardiac Resynchronization Therapy) Phase 4
Completed NCT02355418 - The Role of Myocardial Fibrosis in Degenerative Mitral Regurgitation
Not yet recruiting NCT01431222 - Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery Phase 4
Completed NCT01841554 - Cardioband With Transfemoral Delivery System N/A
Not yet recruiting NCT03870516 - Left Chamber Function in Mitral Regurgitation and Predicting Outcome After Replacement and Targeting for Early Surgery N/A
Active, not recruiting NCT03230747 - SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation N/A
Enrolling by invitation NCT04031274 - Transcatheter Treatment for Combined Aortic and Mitral Valve Disease. The Aortic+Mitral TRAnsCatheter (AMTRAC) Valve Registry
Completed NCT05850026 - Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy: Fix it in a Simple, Effective and Durable Way!
Completed NCT05836480 - Immediate Suboptimal Result of Mitral Valve Repair: Late Implications in a Matched Cohort Study
Completed NCT05836532 - Long Term Results of Surgical and Percutaneous Double Orefices Mitral Repair in Patient With p2 Prolapse Causing Degenerative Mitral Regurgitation
Recruiting NCT03975998 - Dutch-AMR: Early Mitral Valve Repair Versus Watchful Waiting in Asymptomatic Patients With Severe Mitral Regurgitation
Completed NCT01162083 - Identifying an Ideal Cardiopulmonary Exercise Test Parameter N/A
Suspended NCT00787293 - Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients Phase 2